• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估候选工具在评估银屑病关节炎患者的身体功能领域的表现。

Appraisal of Candidate Instruments for Assessment of the Physical Function Domain in Patients with Psoriatic Arthritis.

机构信息

Y.Y. Leung, MB ChB, MD, Associate Professor, Duke-NUS Medical School, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore

A.M. Orbai, MD, MHS, Assistant Professor of Medicine, Director Psoriatic Arthritis Program, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

J Rheumatol. 2021 Jan 1;48(1):58-66. doi: 10.3899/jrheum.191119. Epub 2020 Feb 1.

DOI:10.3899/jrheum.191119
PMID:
32007934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9581582/
Abstract

OBJECTIVE

Numerous patient-reported outcome measures (PROM) exist for the measurement of physical function for psoriatic arthritis (PsA), but only a few are validated comprehensively. The objective of this project was to prioritize PROM for measuring physical function for potential incorporation into a standardized outcome measurement set for PsA.

METHODS

A working group of 13 members including 2 patient research partners was formed. PROM measuring physical function in PsA were identified through a systematic literature review and recommendations by the working group. The rationale for inclusion and exclusion from the original list of existing PROM was thoroughly discussed and 2 rounds of Delphi exercises were conducted to achieve consensus.

RESULTS

Twelve PROM were reviewed and discussed. Six PROM were prioritized: Health Assessment Questionnaire (HAQ) and 4 modifications (HAQ-Disability Index, HAQ-Spondyloarthritis, modified HAQ, multidimensional HAQ), Medical Outcomes Study 36-item Short Form survey physical functioning domain, and the Patient-Reported Outcomes Measurement Information System (PROMIS) physical functioning module.

CONCLUSION

Through discussion and Delphi exercises, we achieved consensus to prioritize 6 physical function PROM for PsA. These 6 PROM will undergo further appraisal using the Outcome Measures in Rheumatology (OMERACT) Filter 2.1.

摘要

目的

有许多针对银屑病关节炎(PsA)的患者报告结局测量(PROM)用于测量身体功能,但只有少数经过全面验证。本项目的目的是优先选择用于测量 PsA 身体功能的 PROM,以潜在纳入 PsA 的标准化结局测量集。

方法

成立了一个由 13 名成员组成的工作组,其中包括 2 名患者研究伙伴。通过系统文献回顾和工作组的建议,确定了用于测量 PsA 身体功能的 PROM。对原始 PROM 列表中的纳入和排除的基本原理进行了深入讨论,并进行了 2 轮 Delphi 练习以达成共识。

结果

共审查和讨论了 12 个 PROM。优先考虑了 6 个 PROM:健康评估问卷(HAQ)及其 4 种变体(HAQ 残疾指数、HAQ 脊柱关节炎、改良 HAQ、多维 HAQ)、医疗结局研究 36 项简短调查问卷的身体功能域以及患者报告结局测量信息系统(PROMIS)身体功能模块。

结论

通过讨论和 Delphi 练习,我们就优先考虑用于评估 PsA 的 6 种身体功能 PROM 达成了共识。这 6 个 PROM 将使用风湿病结局测量(OMERACT)筛选器 2.1 进行进一步评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2ba/9581582/e826a4ce03cc/nihms-1550396-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2ba/9581582/e826a4ce03cc/nihms-1550396-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2ba/9581582/e826a4ce03cc/nihms-1550396-f0001.jpg

相似文献

1
Appraisal of Candidate Instruments for Assessment of the Physical Function Domain in Patients with Psoriatic Arthritis.评估候选工具在评估银屑病关节炎患者的身体功能领域的表现。
J Rheumatol. 2021 Jan 1;48(1):58-66. doi: 10.3899/jrheum.191119. Epub 2020 Feb 1.
2
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.GRAPPA 2020 年年会推荐用于银屑病关节炎的测量身体功能的工具:GRAPPA-OMERACT 工作组的更新。
J Rheumatol Suppl. 2021 Jun;97:60-63. doi: 10.3899/jrheum.201679.
3
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative.一项针对银屑病关节炎患者报告结局测量的测量特性的系统评价:GRAPPA-OMERACT 倡议。
Semin Arthritis Rheum. 2018 Apr;47(5):654-665. doi: 10.1016/j.semarthrit.2017.09.002. Epub 2017 Sep 9.
4
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.银屑病关节炎随机对照试验5种候选工具的内容效度、表面效度和可行性:2017年GRAPPA年会的银屑病关节炎OMERACT核心集研讨会
J Rheumatol Suppl. 2018 Jun;94:17-25. doi: 10.3899/jrheum.180142.
5
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF.OMERACT筛选标准2.1:银屑病关节炎身体功能领域的仪器选择——HAQ-DI和SF-36身体功能量表的临时认可
Semin Arthritis Rheum. 2021 Oct;51(5):1117-1124. doi: 10.1016/j.semarthrit.2021.07.014. Epub 2021 Jul 24.
6
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.启动对银屑病关节炎综合结局指标的评估:GRAPPA-OMERACT 工作组的 2022 年更新。
J Rheumatol. 2023 Nov;50(Suppl 2):53-57. doi: 10.3899/jrheum.2023-0530. Epub 2023 Jul 7.
7
Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.评估银屑病关节炎症状:银屑病临床试验中的核心领域。
J Am Acad Dermatol. 2020 Jan;82(1):54-61. doi: 10.1016/j.jaad.2019.05.075. Epub 2019 Jun 1.
8
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.银屑病和银屑病关节炎研究与评估小组/风湿病学结局指标共识推荐意见及银屑病关节炎中使用复合指标和治疗目标的研究计划。
Arthritis Rheumatol. 2018 Mar;70(3):345-355. doi: 10.1002/art.40391. Epub 2018 Feb 6.
9
Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.更新银屑病关节炎(PsA)核心领域集:来自 2016 年 OMERACT 会议上的 PsA 研讨会的报告。
J Rheumatol. 2017 Oct;44(10):1522-1528. doi: 10.3899/jrheum.160904. Epub 2017 Feb 1.
10
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.PsAID12 在 2018 年 OMERACT 会议上被临时认可为评估临床试验中银屑病关节炎特异性健康相关生活质量的核心结局测量指标。
J Rheumatol. 2019 Aug;46(8):990-995. doi: 10.3899/jrheum.181077. Epub 2018 Dec 15.

引用本文的文献

1
Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study.在治疗银屑病关节炎方面,古塞库单抗治疗可显著改善总体健康结局:来自 3 期研究的患者报告结局测量信息系统 29 结果。
Patient. 2022 Nov;15(6):657-668. doi: 10.1007/s40271-022-00588-6. Epub 2022 Jun 30.
2
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF.OMERACT筛选标准2.1:银屑病关节炎身体功能领域的仪器选择——HAQ-DI和SF-36身体功能量表的临时认可
Semin Arthritis Rheum. 2021 Oct;51(5):1117-1124. doi: 10.1016/j.semarthrit.2021.07.014. Epub 2021 Jul 24.
3

本文引用的文献

1
2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis.2019 年美国风湿病学会类风湿关节炎患者报告功能状态评估指标推荐
Arthritis Care Res (Hoboken). 2019 Dec;71(12):1531-1539. doi: 10.1002/acr.24040. Epub 2019 Nov 11.
2
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.2018年年会的GRAPPA-OMERACT银屑病关节炎工作组:核心结局测量集的报告与完成计划
J Rheumatol Suppl. 2019 Jun;95:33-37. doi: 10.3899/jrheum.190122.
3
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.
A comparison of physical function instruments in psoriatic arthritis: HAQ-DI vs MDHAQ vs PROMIS10 global physical health.
银屑病关节炎中身体功能评估工具的比较:HAQ-DI 与 MDHAQ 与 PROMIS10 全球身体健康。
Rheumatology (Oxford). 2021 May 14;60(5):2307-2316. doi: 10.1093/rheumatology/keaa591.
使用 OMERACT 筛选器 2.1 进行仪器选择:OMERACT 方法学。
J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.
4
Trajectory of radiographic change over a decade: the effect of transition from conventional synthetic disease-modifying antirheumatic drugs to anti-tumour necrosis factor in patients with psoriatic arthritis.十年来影像学改变的轨迹:从传统合成改善病情抗风湿药物向抗肿瘤坏死因子治疗转变对银屑病关节炎患者的影响。
Rheumatology (Oxford). 2019 Feb 1;58(2):269-273. doi: 10.1093/rheumatology/key297.
5
Functional impairment measurement in psoriatic arthritis: Importance and challenges.在银屑病关节炎中进行功能障碍测量:重要性和挑战。
Semin Arthritis Rheum. 2018 Dec;48(3):436-448. doi: 10.1016/j.semarthrit.2018.05.010. Epub 2018 May 23.
6
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.银屑病关节炎随机对照试验5种候选工具的内容效度、表面效度和可行性:2017年GRAPPA年会的银屑病关节炎OMERACT核心集研讨会
J Rheumatol Suppl. 2018 Jun;94:17-25. doi: 10.3899/jrheum.180142.
7
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study).司库奇尤单抗治疗中重度银屑病患者 5 年,疗效持久且安全性良好(SCULPTURE 扩展研究)。
J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1507-1514. doi: 10.1111/jdv.14878. Epub 2018 Mar 22.
8
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative.一项针对银屑病关节炎患者报告结局测量的测量特性的系统评价:GRAPPA-OMERACT 倡议。
Semin Arthritis Rheum. 2018 Apr;47(5):654-665. doi: 10.1016/j.semarthrit.2017.09.002. Epub 2017 Sep 9.
9
GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies.GRAPPA-OMERACT倡议:银屑病关节炎临床试验和纵向观察性研究结果标准化
Ann Rheum Dis. 2018 May;77(5):e23. doi: 10.1136/annrheumdis-2017-212004. Epub 2017 Jul 26.
10
How are enthesitis, dactylitis and nail involvement measured and reported in recent clinical trials of psoriatic arthritis? A systematic literature review.在银屑病关节炎的近期临床试验中,附着点炎、指(趾)炎和指甲受累情况是如何测量和报告的?一项系统文献综述。
Ann Rheum Dis. 2018 May;77(5):782-783. doi: 10.1136/annrheumdis-2017-211447. Epub 2017 Jun 5.